[Special Stock] Shinil Pharmaceutical, Diarrhea Medicine Hoarding Due to COVID-19 Variant in China... Increased Focus on Diarrhea Medicine Sales↑

[Asia Economy Reporter Jang Hyowon] Shinil Pharmaceutical is showing strong performance. As rumors spread in China that a COVID-19 variant causes diarrhea, leading to panic buying of antidiarrheal drugs, Shinil Pharmaceutical, which holds antidiarrheal products, is drawing attention.

As of 9:52 AM on the 3rd, Shinil Pharmaceutical is trading at 8,760 KRW, up 1.98% compared to the previous day.

According to foreign media reports the day before, rumors have spread in China that a new COVID-19 variant causes abdominal pain and diarrhea, triggering panic buying of antidiarrheal drugs.

On online pharmaceutical sales platforms, various antidiarrheal drugs quickly sold out, causing shortages. The price of the antidiarrheal drug Mengtuosan, which was 7 yuan (about 1,290 KRW) per box, surged nearly fivefold to 36.5 yuan (about 6,700 KRW) in one day.

Shinil Pharmaceutical supplies about 190 pharmaceutical products, including tablets, capsules, syrups, ointments/creams, injections, plasters, and patches, to medical institutions. Among its products is the over-the-counter antidiarrheal drug ‘Bicstop,’ which is effective for diarrhea and abdominal pain.